{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:28:34Z","timestamp":1788290914076,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang College Students Innovative Entrepreneurial Training Program","award":["2025R413A034"],"award-info":[{"award-number":["2025R413A034"]}]},{"name":"National Innovation and Entrepreneurship Training Program for College Students","award":["202510343031"],"award-info":[{"award-number":["202510343031"]}]},{"DOI":"10.13039\/501100008990","name":"Science Technology Department of Zhejiang Province","doi-asserted-by":"crossref","award":["2023C03106"],"award-info":[{"award-number":["2023C03106"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atropine is an effective agent for myopia control; however, clinical reports have indicated potential side effects associated with inducing or exacerbating dry eye disease (DED). It remains unclear whether the therapeutic targets involved in atropine-mediated myopia control overlap with those potentially associated with ocular surface effects. Therefore, this study aimed to characterise the shared or distinct target landscape and plausible molecular pathways through which atropine may contribute to myopia control while also being associated with dry eye-related symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In silico analysis was performed to explore the molecular interactions of atropine in controlling myopia and DED. The target lists for atropine, myopia, and DED were sourced from six public databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses identified common and unique pathways. A protein\u2013protein interaction (PPI) network was created and analysed using Cytoscape to identify hub genes using six ranking algorithms. Targets were stratified into shared Class I and myopia-prioritised Class II categories by integrating retinal and pan-ocular expression data. Molecular docking and molecular dynamics (MD) simulations were conducted to assess the binding affinities of atropine to prioritised targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 57 shared Class I and 19 Class II myopia-prioritised targets were identified; 19 hub genes were consistently ranked across the six algorithms. Class I targets converge on inflammatory and extracellular-matrix-remodelling pathways. Evidence of ocular expression supports the biological relevance of the prioritised targets in both classes. Docking showed favourable atropine binding to representative Class I targets (EGFR, MMP2, MMP9, and MAPK1) and Class II candidates (PIK3R1 and AKR1B1). MD simulations supported stable complexes for eight atropine-target pairs, with MM-PBSA binding free energy estimates supporting the computational prioritisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Shared Class I targets may potentially link the effects of atropine on both myopia control and DED, along with Class II targets specific to myopia, thereby generating testable hypotheses regarding the dual ocular effects of atropine and informing future mechanistic and translational studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40662-026-00493-1","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T01:41:11Z","timestamp":1782092471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Network pharmacology and molecular dynamics simulations reveal shared mechanisms and myopia-specific targets of atropine in myopia and dry eye disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Meng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyi","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"5","key":"493_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/OPX.0000000000002249","volume":"102","author":"D Horn","year":"2025","unstructured":"Horn D, Salzano AD, Jenewein EC, Weise KK, Schaeffel F, Mathis U, et al. Topical review: potential mechanisms of atropine for myopia control. Optom Vis Sci. 2025;102(5):260\u201370.","journal-title":"Optom Vis Sci"},{"issue":"11","key":"493_CR2","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.18240\/ijo.2024.11.20","volume":"17","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Chen L, Liang JR, Hu M, Xue LP, Zhou GL, et al. Retardation of myopia by atropine regimes. Int J Ophthalmol. 2024;17(11):2129\u201340.","journal-title":"Int J Ophthalmol"},{"key":"493_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1509196","volume":"16","author":"L Huang","year":"2025","unstructured":"Huang L, Zhang J, Luo Y. The role of atropine in myopia control: insights into choroidal and scleral mechanisms. Front Pharmacol. 2025;16:1509196.","journal-title":"Front Pharmacol"},{"issue":"1","key":"493_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50309-w","volume":"15","author":"B Zhao","year":"2024","unstructured":"Zhao B, Li Y, Fan Z, Wu Z, Shu J, Yang X, et al. Eye-brain connections revealed by multimodal retinal and brain imaging genetics. Nat Commun. 2024;15(1):6064.","journal-title":"Nat Commun"},{"key":"493_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109331","volume":"132","author":"F Zhao","year":"2019","unstructured":"Zhao F, Ma JX. Will the long-term use of atropine eye drops in children increase the risk of dry eye? Med Hypotheses. 2019;132:109331.","journal-title":"Med Hypotheses"},{"key":"493_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2025.108656","volume":"234","author":"JT Lloyd","year":"2025","unstructured":"Lloyd JT, Collins AV, Phillips JR, Acosta ML. Atropine restores retinal glutamate \/ \u03b3-aminobutyric acid levels in vitro in an experimental chick model of myopia. Vision Res. 2025;234:108656.","journal-title":"Vision Res"},{"issue":"1","key":"493_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12886-024-03309-9","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li L, Tang X, Fan H, Song W, Xie J, et al. The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia. BMC Ophthalmol. 2024;24(1):41.","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"493_CR8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/kjm2.12598","volume":"38","author":"XJ Chen","year":"2022","unstructured":"Chen XJ, Hu P, Yi S. High-concentration atropine induces corneal epithelial cell apoptosis via miR-30c-1\/SOCS3. Kaohsiung J Med Sci. 2022;38(11):1113\u201322.","journal-title":"Kaohsiung J Med Sci"},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"1436551","DOI":"10.3389\/fmed.2024.1436551","volume":"11","author":"M Li","year":"2024","unstructured":"Li M, Chen Y, Chen J, Qin G, Li L, He W, et al. Short-term effects of ophthalmic topical 0.01% atropine on the ocular surface, pupil size, and subsequent subjective quality of vision in young myopic Chinese adults. Front Med (Lausanne). 2024;11:1436551.","journal-title":"Front Med (Lausanne)."},{"key":"493_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151614","volume":"758","author":"B Sharma","year":"2025","unstructured":"Sharma B, Purohit R. Enhanced sampling simulations to explore Himalayan phytochemicals as potential phosphodiesterase-1 inhibitor for neurological disorders. Biochem Biophys Res Commun. 2025;758:151614.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"493_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2023.105279","volume":"26","author":"R Singh","year":"2024","unstructured":"Singh R, Manna S, Nandanwar H, Purohit R. Bioactives from medicinal herb against bedaquiline resistant tuberculosis: removing the dark clouds from the horizon. Microbes Infect. 2024;26(3):105279.","journal-title":"Microbes Infect"},{"issue":"3","key":"493_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30532","volume":"125","author":"A Gupta","year":"2024","unstructured":"Gupta A, Purohit R. Identification of potent BRD4-BD1 inhibitors using classical and steered molecular dynamics based free energy analysis. J Cell Biochem. 2024;125(3):e30532.","journal-title":"J Cell Biochem"},{"issue":"18","key":"493_CR13","doi-asserted-by":"publisher","first-page":"8831","DOI":"10.1080\/07391102.2022.2137699","volume":"41","author":"A Dhiman","year":"2023","unstructured":"Dhiman A, Purohit R. Identification of potential mutational hotspots in serratiopeptidase to address its poor pH tolerance issue. J Biomol Struct Dyn. 2023;41(18):8831\u201343.","journal-title":"J Biomol Struct Dyn"},{"issue":"19","key":"493_CR14","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.1080\/07391102.2022.2141895","volume":"41","author":"B Sharma","year":"2023","unstructured":"Sharma B, Bhattacherjee D, Zyryanov GV, Purohit R. An insight from computational approach to explore novel, high-affinity phosphodiesterase 10A inhibitors for neurological disorders. J Biomol Struct Dyn. 2023;41(19):9424\u201336.","journal-title":"J Biomol Struct Dyn"},{"issue":"30","key":"493_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202401708","volume":"9","author":"VH Pandya","year":"2024","unstructured":"Pandya VH, Sufiyan Chhipa A, Kalariya RN, Modi KM, Rana S, Patel C, et al. Discovery and biological evaluation of novel fluorinated derivatives of benzophenone analogues as potent anti-cancer agent: synthesis, in vitro assay and molecular dynamics. ChemistrySelect. 2024;9(30):e202401708.","journal-title":"ChemistrySelect"},{"issue":"3","key":"493_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.25004\/IJPSDR.2020.120310","volume":"12","author":"H Pandya","year":"2020","unstructured":"Pandya H, Patel CN, Bhavsar M, Pandya PN, Patel SK, Rawal RM. Analyzing the role of phytochemicals in targeting drug transporter protein ABCC6 using molecular docking and molecular dynamics simulations. Int J Pharm Sci Drug Res. 2020;12(3):275\u201381.","journal-title":"Int J Pharm Sci Drug Res"},{"issue":"D1","key":"493_CR17","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44(D1):D1202\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"493_CR18","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357\u201364.","journal-title":"Nucleic Acids Res"},{"key":"493_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-016-0130-x","volume":"8","author":"Z Wang","year":"2016","unstructured":"Wang Z, Liang L, Yin Z, Lin J. Improving chemical similarity ensemble approach in target prediction. J Cheminform. 2016;8:20.","journal-title":"J Cheminform"},{"issue":"D1","key":"493_CR20","doi-asserted-by":"publisher","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","volume":"51","author":"AP Davis","year":"2023","unstructured":"Davis AP, Wiegers TC, Johnson RJ, Sciaky D, Wiegers J, Mattingly CJ. Comparative Toxicogenomics Database (CTD): update 2023. Nucleic Acids Res. 2023;51(D1):D1257\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"493_CR21","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45(W1):W356\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"493_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky092","volume":"46","author":"UniProt Consortium T","year":"2018","unstructured":"UniProt Consortium T. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2018;46(5):2699.","journal-title":"Nucleic Acids Res"},{"key":"493_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baq020","volume":"2010","author":"M Safran","year":"2010","unstructured":"Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, et al. GeneCards Version 3: the human gene integrator. Database (Oxford). 2010;2010:baq020.","journal-title":"Database (Oxford)"},{"issue":"D1","key":"493_CR24","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","volume":"45","author":"N Rappaport","year":"2017","unstructured":"Rappaport N, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J, et al. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2017;45(D1):D877\u201387.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"493_CR25","doi-asserted-by":"publisher","first-page":"D1467","DOI":"10.1093\/nar\/gkae1128","volume":"53","author":"A Buniello","year":"2025","unstructured":"Buniello A, Suveges D, Cruz-Castillo C, Llinares MB, Cornu H, Lopez I, et al. Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Res. 2025;53(D1):D1467\u201375.","journal-title":"Nucleic Acids Res"},{"key":"493_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience. 2015;4:7.","journal-title":"GigaScience"},{"issue":"7319","key":"493_CR27","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","volume":"467","author":"GR Abecasis","year":"2010","unstructured":"1000 Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061\u201373.","journal-title":"Nature"},{"key":"493_CR28","doi-asserted-by":"crossref","unstructured":"Garcia-Gonzalez J, Cote AC, Garcia-Gonzalez S, Liou L, O'Reilly PF. The gene expression landscape of disease genes. medRxiv. 2025.","DOI":"10.1101\/2024.06.20.24309121"},{"key":"493_CR29","doi-asserted-by":"publisher","first-page":"W169","DOI":"10.1093\/nar\/gkm415","volume":"35","author":"DW Huang","year":"2007","unstructured":"Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35:W169\u201375.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"493_CR30","doi-asserted-by":"publisher","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"SA Aleksander","year":"2023","unstructured":"Gene Ontology Consortium, Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, et al. The gene ontology knowledgebase in 2023. Genetics. 2023;224(1):iyad031.","journal-title":"Genetics"},{"issue":"D1","key":"493_CR31","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 4","key":"493_CR32","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"8","key":"493_CR33","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1167\/iovs.19-27106","volume":"60","author":"V Swamy","year":"2019","unstructured":"Swamy V, McGaughey D. Eye in a disk: eyeIntegration human pan-eye and body transcriptome database version 1.0. Invest Ophthalmol Vis Sci. 2019;60(8):3236\u201346.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Web Server issu","key":"493_CR34","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Web Server issue):W214\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"493_CR35","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gkae1142","volume":"53","author":"S Abdulla","year":"2025","unstructured":"CZI Cell Science Program, Abdulla S, Aevermann B, Assis P, Badajoz S, Bell SM, et al. CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data. Nucleic Acids Res. 2025;53(D1):D886-900.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"493_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H. The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235\u201342.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"493_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"16","key":"493_CR38","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785\u201391.","journal-title":"J Comput Chem"},{"issue":"W1","key":"493_CR39","doi-asserted-by":"publisher","first-page":"W48","DOI":"10.1093\/nar\/gkaa235","volume":"48","author":"K Sch\u00f6ning-Stierand","year":"2020","unstructured":"Sch\u00f6ning-Stierand K, Diedrich K, F\u00e4hrrolfes R, Flachsenberg F, Meyder A, Nittinger E, et al. ProteinsPlus: interactive analysis of protein-ligand binding interfaces. Nucleic Acids Res. 2020;48(W1):W48-53.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"493_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1389450119666181022153016","volume":"20","author":"S Saikia","year":"2019","unstructured":"Saikia S, Bordoloi M. Molecular docking: challenges, advances and its use in drug discovery perspective. Curr Drug Targets. 2019;20(5):501\u201321.","journal-title":"Curr Drug Targets"},{"issue":"16","key":"493_CR41","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701\u201318.","journal-title":"J Comput Chem"},{"issue":"8","key":"493_CR42","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11(8):3696\u2013713.","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"493_CR43","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general Amber force field. J Comput Chem. 2004;25(9):1157\u201374.","journal-title":"J Comput Chem"},{"issue":"22","key":"493_CR44","doi-asserted-by":"publisher","DOI":"10.1063\/5.0004608","volume":"152","author":"F Neese","year":"2020","unstructured":"Neese F, Wennmohs F, Becker U, Riplinger C. The ORCA quantum chemistry program package. J Chem Phys. 2020;152(22):224108.","journal-title":"J Chem Phys"},{"issue":"5","key":"493_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F. Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem. 2012;33(5):580\u201392.","journal-title":"J Comput Chem"},{"issue":"1","key":"493_CR46","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007;126(1):014101.","journal-title":"J Chem Phys"},{"issue":"1","key":"493_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1021\/ct700200b","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess B. P-LINCS: a parallel linear constraint solver for molecular simulation. J Chem Theory Comput. 2008;4(1):116\u201322.","journal-title":"J Chem Theory Comput"},{"issue":"2","key":"493_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"N Homeyer","year":"2012","unstructured":"Homeyer N, Gohlke H. Free energy calculations by the molecular mechanics Poisson-Boltzmann surface area method. Mol Inform. 2012;31(2):114\u201322.","journal-title":"Mol Inform"},{"issue":"8","key":"493_CR49","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","volume":"27","author":"E Papaleo","year":"2009","unstructured":"Papaleo E, Mereghetti P, Fantucci P, Grandori R, De Gioia L. Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. J Mol Graph Model. 2009;27(8):889\u201399.","journal-title":"J Mol Graph Model"},{"issue":"3","key":"493_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","volume":"46","author":"A Upadhyay","year":"2020","unstructured":"Upadhyay A, Beuerman RW. Biological mechanisms of atropine control of myopia. Eye Contact Lens. 2020;46(3):129\u201335.","journal-title":"Eye Contact Lens"},{"issue":"3","key":"493_CR51","first-page":"157","volume":"7","author":"R Kaiti","year":"2022","unstructured":"Kaiti R, Shyangbo R, Sharma IP. Role of atropine in the control of myopia progression- a review. Beyoglu Eye J. 2022;7(3):157\u201366.","journal-title":"Beyoglu Eye J"},{"key":"493_CR52","first-page":"680","volume":"17","author":"VA Barathi","year":"2011","unstructured":"Barathi VA, Beuerman RW. Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: prior to and after induction of experimental myopia with atropine treatment. Mol Vis. 2011;17:680\u201392.","journal-title":"Mol Vis"},{"issue":"22","key":"493_CR53","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1111\/bph.15629","volume":"178","author":"K Thomson","year":"2021","unstructured":"Thomson K, Kelly T, Karouta C, Morgan I, Ashby R. Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release. Br J Pharmacol. 2021;178(22):4501\u201317.","journal-title":"Br J Pharmacol"},{"key":"493_CR54","doi-asserted-by":"publisher","first-page":"1260592","DOI":"10.3389\/fimmu.2023.1260592","volume":"14","author":"R Xu","year":"2023","unstructured":"Xu R, Zheng J, Liu L, Zhang W. Effects of inflammation on myopia: evidence and potential mechanisms. Front Immunol. 2023;14:1260592.","journal-title":"Front Immunol"},{"key":"493_CR55","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2147\/OPTH.S523283","volume":"19","author":"X Yin","year":"2025","unstructured":"Yin X, Ge J. The role of scleral changes in the progression of myopia: a review and future directions. Clin Ophthalmol. 2025;19:1699\u2013707.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"493_CR56","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1159\/000524502","volume":"65","author":"L Liu","year":"2022","unstructured":"Liu L, Zhou W, Fan Y, Zhang L, Liu S, Song S, et al. Effect of interleukin 6 on scleral fibroblast proliferation, differentiation, and apoptosis involved in myopic scleral remodeling. Ophthalmic Res. 2022;65(5):529\u201339.","journal-title":"Ophthalmic Res"},{"issue":"13","key":"493_CR57","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.7150\/ijbs.101438","volume":"20","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Lv L, Chen D, Li F, Zhou J. Molecular changes in intraocular fluid: implications for myopia. Int J Biol Sci. 2024;20(13):5330\u201342.","journal-title":"Int J Biol Sci"},{"key":"493_CR58","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.91289","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen C, Liu Q, Tang C, Rong Y, Zhao X, Li D, et al. ZC3H11A mutations cause high myopia by triggering PI3K-AKT and NF-kappaB-mediated signaling pathway in humans and mice. Elife. 2025;12:RP91289.","journal-title":"Elife"},{"issue":"10","key":"493_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258203","volume":"16","author":"YH Lee","year":"2021","unstructured":"Lee YH, Bang SP, Shim KY, Son MJ, Kim H, Jun JH. Association of tear matrix metalloproteinase 9 immunoassay with signs and symptoms of dry eye disease: a cross-sectional study using qualitative, semiquantitative, and quantitative strategies. PLoS One. 2021;16(10):e0258203.","journal-title":"PLoS One"},{"issue":"10","key":"493_CR60","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.3390\/ijms23105639","volume":"23","author":"M de la Fuente","year":"2022","unstructured":"de la Fuente M, Rodriguez-Agirretxe I, Vecino E, Astigarraga E, Acera A, Barreda-Gomez G. Elevation of tear MMP-9 concentration as a biomarker of inflammation in ocular pathology by antibody microarray immunodetection assays. Int J Mol Sci. 2022;23(10):5639.","journal-title":"Int J Mol Sci"},{"key":"493_CR61","doi-asserted-by":"publisher","first-page":"1384500","DOI":"10.3389\/fmed.2024.1384500","volume":"11","author":"J Gong","year":"2024","unstructured":"Gong J, Ding G, Hao Z, Li Y, Deng A, Zhang C. Elucidating the mechanism of corneal epithelial cell repair: unraveling the impact of growth factors. Front Med (Lausanne). 2024;11:1384500.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"493_CR62","first-page":"1031","volume":"8","author":"Y Yang","year":"2025","unstructured":"Yang Y, Lee D, Gettinger K, Tsubota K, Negishi K, Kurihara T, et al. Mechanisms underlying myopia progression from visual signaling to metabolic remodeling in retina. JMA J. 2025;8(4):1031\u20138.","journal-title":"JMA J"},{"issue":"9","key":"493_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.66.9.5","volume":"66","author":"H Zhou","year":"2025","unstructured":"Zhou H, Zhou G, Yang Q, Niu J, Wang R, Liu H, et al. Evidence for M2 muscarinic receptor antagonist delay of myopia development through activation of Kir3.4 channel in the retina of guinea pigs. Invest Ophthalmol Vis Sci. 2025;66(9):5.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"493_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2147\/TCRM.S265945","volume":"16","author":"J Cheng","year":"2020","unstructured":"Cheng J, Yang Y, Kong X, Zeng L, Chen Z, Xu J, et al. The effect of 0.01% atropine eye drops on the ocular surface in children for the control of myopia-the primary results from a six-month prospective study. Ther Clin Risk Manag. 2020;16:735\u201340.","journal-title":"Ther Clin Risk Manag"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-026-00493-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-026-00493-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-026-00493-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:28:02Z","timestamp":1782098882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40662-026-00493-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1186\/s40662-026-00493-1","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not include experiments involving human participants or animals. All the data were obtained from publicly available databases and published studies. Therefore, ethical approval and informed consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof. Jia Qu is the editor in chief of Eye and Vision. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}